Solini A - Search Results

1

Clinical efficacy and cost-effectiveness of metformin in different patient populations: A narrative review of real-world evidence.

Solini A, Tricò D. Solini A, et al. Diabetes Obes Metab. 2024 Aug;26 Suppl 3:20-30. doi: 10.1111/dom.15729. Epub 2024 Jun 28. Diabetes Obes Metab. 2024. PMID: 38939954 Review.

2

Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes.

Solini A, Rossi C, Mazzanti CM, Proietti A, Koepsell H, Ferrannini E. Solini A, et al. Diabetes Obes Metab. 2017 Sep;19(9):1289-1294. doi: 10.1111/dom.12970. Epub 2017 May 22. Diabetes Obes Metab. 2017. PMID: 28419670

3

Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.

Orsi E, Solini A, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Gruden G, Morano S, Nicolucci A, Penno G, Pugliese G; Renal Insufficiency and Cardiovascular Events (RIACE) Study Group. Orsi E, et al. Among authors: solini a. Diabetes Obes Metab. 2018 Aug;20(8):1885-1893. doi: 10.1111/dom.13306. Epub 2018 Apr 19. Diabetes Obes Metab. 2018. PMID: 29582548

4

Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study.

Fadini GP, Solini A, Manca ML, Penno G, Gatti A, Anichini R, Del Prato S, Avogaro A; DARWIN-T2D Network. Fadini GP, et al. Among authors: solini a. Diabetes Obes Metab. 2019 Feb;21(2):252-260. doi: 10.1111/dom.13508. Epub 2018 Sep 21. Diabetes Obes Metab. 2019. PMID: 30136354 Free PMC article.

5

Cardiovascular protection with sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: Does it apply to all patients?

Giorgino F, Vora J, Fenici P, Solini A. Giorgino F, et al. Among authors: solini a. Diabetes Obes Metab. 2020 Sep;22(9):1481-1495. doi: 10.1111/dom.14055. Epub 2020 May 7. Diabetes Obes Metab. 2020. PMID: 32285611 Free PMC article. Review.

6

Protein and amino acids in nonalcoholic fatty liver disease.

Tricò D, Biancalana E, Solini A. Tricò D, et al. Among authors: solini a. Curr Opin Clin Nutr Metab Care. 2021 Jan;24(1):96-101. doi: 10.1097/MCO.0000000000000706. Curr Opin Clin Nutr Metab Care. 2021. PMID: 33060460 Review.

7

Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?

Giaccari A, Solini A, Frontoni S, Del Prato S. Giaccari A, et al. Among authors: solini a. Diabetes Care. 2021 Mar;44(3):647-654. doi: 10.2337/dc20-1964. Diabetes Care. 2021. PMID: 33608326 Free PMC article. Review.

8

MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance.

Bianchi C, Raggi F, Rossi C, Frontoni S, Bonadonna RC, Del Prato S, Solini A. Bianchi C, et al. Among authors: solini a. Diabetes Metab. 2022 Mar;48(2):101292. doi: 10.1016/j.diabet.2021.101292. Epub 2021 Oct 19. Diabetes Metab. 2022. PMID: 34678488

9

Challenges and opportunities in real-world evidence on the renal effects of sodium-glucose cotransporter-2 inhibitors.

Fadini GP, Del Prato S, Avogaro A, Solini A. Fadini GP, et al. Among authors: solini a. Diabetes Obes Metab. 2022 Feb;24(2):177-186. doi: 10.1111/dom.14599. Epub 2021 Nov 24. Diabetes Obes Metab. 2022. PMID: 34747123 Free PMC article. Review.

10

Glucagon-Like Peptide-1 Receptor Agonists-Use in Clinical Practice.

Tricò D, Solini A. Tricò D, et al. Among authors: solini a. Adv Chronic Kidney Dis. 2021 Jul;28(4):328-336. doi: 10.1053/j.ackd.2021.04.002. Adv Chronic Kidney Dis. 2021. PMID: 34922689 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters